147
Views
2
CrossRef citations to date
0
Altmetric
Original Article

The risk of developing a mismatch repair deficient colorectal cancer after undergoing cholecystectomy

, , ORCID Icon, , , , , & show all
Pages 972-975 | Received 14 May 2018, Accepted 17 May 2018, Published online: 16 Jul 2018
 

Abstract

Objectives: Mismatch repair deficient (dMMR) colorectal cancer (CRC) is caused by inactivation of the MMR DNA repair system, most commonly via epigenetic inactivation of the MLH1 gene, and these tumors occur most frequently in the right colon. The objective was to determine whether cholecystectomy (CCY) increases the risk of a dMMR CRC by comparing CCY incidence in patients with dMMR CRC and proficient MMR (pMMR) CRC to unaffected controls.

Materials and methods: All patients diagnosed with CRC in Iceland from 2000 to 2009 (n = 1171) were included. They had previously been screened for dMMR by immunohistochemistry (n = 129 were dMMR). Unaffected age- and sex-matched controls (n = 17,460) were obtained from large Icelandic cohort studies. Subjects were cross-referenced with all pathology databases in Iceland to establish who had undergone CCY. Odds ratios were calculated using unconditional logistic regression.

Results: Eighteen (13.7%) dMMR CRC cases and 90 (8.7%) pMMR CRC cases had undergone CCY compared to 1532 (8.8%) controls. CCY-related odds ratios (OR) were 1.06 (95% CI 0.90–1.26, p = .577) for all CRC, 1.16 (95% CI 0.66–2.05 p = .602) for dMMR CRCand 1.04 (95% CI 0.83–1.29, p = .744) for pMMR CRC. Furthermore, OR for dMMR CRC was 0.51 (95% CI 0.16–1.67, p = .266), 2.04 (95% CI 0.92–4.50, p = .080) and 1.08 (95% CI 0.40–2.89, p = .875) <10 years, 10–20 years and >20 years after a CCY, respectively.

Conclusions: There was no evidence of increased risk of developing dMMR CRC after CCY although a borderline significantly increased 2-fold risk was observed 10–20 years after CCY. Larger studies are warranted to examine this further.

Acknowledgements

We are grateful for all the work GuĐríĐur Helga Ólafsdóttir at Icelandic Cancer institution has done for the study. We also wish to thank Ingibjörg Richter, Kristín K. Alexíusdóttir and GunnhildurJóhannsdóttir for their contributions to this project.

Disclosure statement

No potential conflict of interest was reported by the authors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.